Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The EMBO Journal|December 6, 2003
A novel docking site on Mediator is critical for activation by VP16 in mammalian cellsGerhard Mittler, Thomas Stühler, Lisa Santolin, et al.
Molecular and Cellular Biology|March 4, 2003
Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivationYousang Gwack, Hwa Jin Baek, Hiroyuki Nakamura, et al.
Molecular and Cellular Biology|July 23, 2014
Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cellsTimothy W R Kelso, Karen Baumgart, Jan Eickhoff, et al.
Science (New York, N.Y.)|December 15, 2007
Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7Rob D Chapman, Martin Heidemann, Thomas K Albert, et al.
Molecular and Cellular Biology|October 29, 2004
NC2alpha interacts with BTAF1 and stimulates its ATP-dependent association with TATA-binding proteinMarcin P Klejman, Lloyd A Pereira, Hester J T van Zeeburg, et al.
Nature Structural & Molecular Biology|March 8, 2011
Structure and VP16 binding of the Mediator Med25 activator interaction domainErika Vojnic, André Mourão, Martin Seizl, et al.
Nature Communications|July 10, 2020
κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitisStephanie Beel, Lina Kolloch, Lisa H Apken, et al.
Nucleic Acids Research|January 17, 2019
Conformational changes and catalytic inefficiency associated with Mot1-mediated TBP-DNA dissociationGregor Heiss, Evelyn Ploetz, Lena Voith von Voithenberg, et al.
Neurogenetics|July 25, 2018
The polynucleotide kinase 3'-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25Alejandro Leal, Sixto Bogantes-Ledezma, Arif B Ekici, et al.
BMC Cancer|June 15, 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cellsKornelius Kerl, David Ries, Rebecca Unland, et al.
Pageof 4